Establishing surrogate kidney endpoints for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes
<p>Objective: Endpoints currently used in lupus nephritis (LN) clinical trials lack uniformity and questionably reflect long‐term kidney survival. The objective of this investigation was to identify short‐term endpoints that predict long‐term kidney outcomes for use in clinical trials.</p&g...
Những tác giả chính: | Mackay, M, Dall’Era, M, Fishbein, J, Kalunian, K, Lesser, M, Guerrero, J, Levy, DM, Silverman, E, Petri, M, Arriens, C, Lewis, EJ, Korbet, SM, Conti, F, Tesar, V, Hruskova, Z, Borba, EF, Bonfa, E, Chan, T, Rathi, M, Gupta, KL, Jha, V, Hasni, S, West, MR, Solomons, N, Houssiau, FA, Diaz, J, Mejia-Vilet, J, Rovin, BH |
---|---|
Định dạng: | Journal article |
Được phát hành: |
Wiley
2019
|
Những quyển sách tương tự
-
P87 Comparison of a voclosporin-based, triple immunotherapy regimen to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV plus AURORA 1 studies and ALMS
Bằng: Kenneth Kalunian, et al.
Được phát hành: (2024-03-01) -
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Bằng: Inker, LA, et al.
Được phát hành: (2023) -
Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease
Bằng: Vonesh, E, et al.
Được phát hành: (2019) -
Rationale for surrogate endpoints and conditional marketing authorization of new therapies for kidney transplantation
Bằng: Naesens, M, et al.
Được phát hành: (2022) -
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS
Bằng: Kenneth Kalunian, et al.
Được phát hành: (2024-11-01)